Thomas Duflot

Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections

Fabien Lamoureux, Thomas Duflot, Jean‐Baptiste Woillard et al. · International Journal of Antimicrobial Agents · 2015 · 102 citations · Full text

Diagnostic Mycology, Fungal Pathogen, Antifungal Agents +13

Development of Improved Double-Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in Peripheral Blood Mononuclear Cells of Diabetic Patients and the Prefrontal Cortex of Multiple Sclerosis Patients

Dongyang Li, Christophe Morisseau, Cindy B. McReynolds et al. · Analytical Chemistry · 2020 · 46 citations · Full text

Nanotherapeutics, Engineering, Prefrontal Cortex +27

Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain

Jan S. Kramer, Stefano Woltersdorf, Thomas Duflot et al. · Journal of Medicinal Chemistry · 2019 · 43 citations · Full text

The right blood collection tube for therapeutic drug monitoring and toxicology screening procedures: Standard tubes, gel or mechanical separator?

Aurélien Schrapp, Céline Mory, Thomas Duflot et al. · Clinica Chimica Acta · 2018 · 33 citations · Full text

Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice

Clothilde Roche, Dominique Guerrot, Najah Harouki et al. · Prostaglandins & Other Lipid Mediators · 2015 · 29 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Disorder +13